Advertisement

Trends in Transcranial Doppler Monitoring in Aneurysmal Subarachnoid Hemorrhage: A 10-Year Analysis of the Nationwide Inpatient Sample

      Background

      Transcranial Doppler (TCD) is endorsed by national guidelines for use in aneurysmal subarachnoid hemorrhage (aSAH) for surveillance of cerebral vasospasm (CV). However, nationwide data on utilization of TCD for CV detection and monitoring in aSAH are lacking.

      Methods

      Analysis of nationwide trends in TCD prevalence was performed using Nationwide Inpatient Sample (NIS) data from 2002 to 2011. Raw counts were converted into weighted counts, which were used to generate national estimates. Teaching hospitals were examined separately for TCD utilization rates. All analyses accounted for the complex sampling design and sample discharge weights of the NIS, following Healthcare Cost and Utilization Project–NIS recommendations. The objective was to estimate the proportion of patients with aSAH receiving TCD monitoring using the NIS.

      Results

      Between 2002 and 2011, a total of 256,089 patients were discharged with a diagnosis of aSAH, of which 3850 underwent TCD monitoring. aSAH accounted for an average of 67.1 discharges per 100,000 annually (95% confidence interval [CI] 61.3-72.8). Of these, 1.5% (95% CI 0.4-2.6) underwent TCD examination. In teaching hospitals, aSAH accounted for an average of 108.5 discharges per 100,000 biennially (95% CI, 96.2-120.8), of which 2% (95% CI 1.0-4.0) underwent TCD examination. TCD utilization increased from <1% during the 2002-2005 period to ≥1.5% during the 2006-2011 period (odds ratio 2.3, 95% CI 1.0-5.7), an increase also seen in teaching hospitals.

      Conclusions

      TCD is underused nationally in the care of aSAH. Whereas the prevalence of TCD is low in teaching hospitals, it is nearly nonexistent in nonteaching hospitals.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kassell N.F.
        • Haley Jr, E.C.
        • Apperson-Hansen C.
        • et al.
        Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
        J Neurosurg. 1996; 84: 221-228
        • Macdonald R.L.
        • Kassell N.F.
        • Mayer S.
        • et al.
        Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
        Stroke. 2008; 39: 3015-3021
        • Neil-Dwyer G.
        • Mee E.
        • Dorrance D.
        • et al.
        Early intervention with nimodipine in subarachnoid haemorrhage.
        Eur Heart J. 1987; 8: 41-47
        • Lysakowski C.
        • Walder B.
        • Costanza M.C.
        • et al.
        Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review.
        Stroke. 2001; 32: 2292-2298
        • Rabinstein A.A.
        • Friedman J.A.
        • Weigand S.D.
        • et al.
        Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.
        Stroke. 2004; 35: 1862-1866
        • Vergouwen M.D.
        • Ilodigwe D.
        • Macdonald R.L.
        Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects.
        Stroke. 2011; 42: 924-929
        • Kassell N.F.
        • Sasaki T.
        • Colohan A.R.
        • et al.
        Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
        Stroke. 1985; 16: 562-572
        • Macdonald R.L.
        • Hunsche E.
        • Schuler R.
        • et al.
        Quality of life and healthcare resource use associated with angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
        Stroke. 2012; 43: 1082-1088
        • Connolly Jr, E.S.
        • Rabinstein A.A.
        • Carhuapoma J.R.
        • et al.
        Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2012; 43: 1711-1737
        • Sloan M.A.
        • Alexandrov A.V.
        • Tegeler C.H.
        • et al.
        Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
        Neurology. 2004; 62: 1468-1481
        • Diringer M.N.
        • Bleck T.P.
        • Claude Hemphill 3rd, J.
        • et al.
        Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.
        Neurocrit Care. 2011; 15: 211-240
        • Kumar G.
        • Shahripour R.B.
        • Harrigan M.R.
        Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
        J Neurosurg. 2016; 124: 1257-1264
        • Lerch C.
        • Yonekawa Y.
        • Muroi C.
        • et al.
        Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage.
        Neurocrit Care. 2006; 5: 85-92
        • Meyer R.
        • Deem S.
        • Yanez N.D.
        • et al.
        Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage.
        Neurocrit Care. 2011; 14: 24-36
        • Angus D.C.
        • Shorr A.F.
        • White A.
        • et al.
        Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations.
        Crit Care Med. 2006; 34: 1016-1024
        • Moppett I.K.
        • Mahajan R.P.
        Transcranial Doppler ultrasonography in anaesthesia and intensive care.
        Br J Anaesth. 2004; 93: 710-724
        • Kumar G.
        • Alexandrov A.V.
        Vasospasm surveillance with transcranial doppler sonography in subarachnoid hemorrhage.
        J Ultrasound Med. 2015; 34: 1345-1350
        • Schmidt J.M.
        • Wartenberg K.E.
        • Fernandez A.
        • et al.
        Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage.
        J Neurosurg. 2008; 109: 1052-1059
        • Dorsch N.W.
        Cerebral arterial spasm—a clinical review.
        Br J Neurosurg. 1995; 9: 403-412
        • Wardlaw J.M.
        • Offin R.
        • Teasdale G.M.
        • et al.
        Is routine transcranial Doppler ultrasound monitoring useful in the management of subarachnoid hemorrhage?.
        J Neurosurg. 1998; 88: 272-276
        • Aaslid R.
        • Huber P.
        • Nornes H.
        A transcranial Doppler method in the evaluation of cerebrovascular spasm.
        Neuroradiology. 1986; 28: 11-16
        • Sviri G.E.
        • Newell D.W.
        • Lewis D.H.
        • et al.
        Impact of basilar artery vasospasm on outcome in patients with severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
        Stroke. 2006; 37: 2738-2743
        • Greenberg E.D.
        • Gold R.
        • Reichman M.
        • et al.
        Diagnostic accuracy of CT angiography and CT perfusion for cerebral vasospasm: a meta-analysis.
        AJNR Am J Neuroradiol. 2010; 31: 1853-1860
        • Mir D.I.
        • Gupta A.
        • Dunning A.
        • et al.
        CT perfusion for detection of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
        AJNR Am J Neuroradiol. 2014; 35: 866-871
        • Ehrlich G.
        • Kirschning T.
        • Wenz H.
        • et al.
        Is there an influence of routine daily transcranial Dopplerexamination on clinical outcome in patients after aneurysmal subarachnoid hemorrhage?.
        World Neurosurg. 2016; 88: 214-221
        • Brown R.J.
        • Kumar A.
        • Dhar R.
        • et al.
        The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
        Neurosurgery. 2013; 72 (discussion 7-8): 702-707
        • Wagner M.
        • Steinbeis P.
        • Guresir E.
        • et al.
        Beyond delayed cerebral vasospasm: infarct patterns in patients with subarachnoid hemorrhage.
        Clin Neuroradiol. 2013; 23: 87-95
        • Dankbaar J.W.
        • Rijsdijk M.
        • van der Schaaf I.C.
        • et al.
        Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
        Neuroradiology. 2009; 51: 813-819
        • Etminan N.
        • Vergouwen M.D.
        • Ilodigwe D.
        • et al.
        Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
        J Cereb Blood Flow Metab. 2011; 31: 1443-1451
        • Tirschwell D.L.
        • Longstreth Jr, W.T.
        Validating administrative data in stroke research.
        Stroke. 2002; 33: 2465-2470
        • Kokotailo R.A.
        • Hill M.D.
        Coding of stroke and stroke risk factors using International Classification of Diseases, revisions 9 and 10.
        Stroke. 2005; 36: 1776-1781